Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 29, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc....
-
Jun 7, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today provided top-line safety and efficacy results from the Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
May 12, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2011 ("Q1 2011"). The first quarter of 2011 represents the...
-
May 5, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced it will host a conference call for its Q1 2011 financial results and hold an Annual & Special Meeting of Shareholders on Thursday, May 12,...
-
Mar 9, 2011
- Results highlighted by 70% increase in revenue - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, March 9 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and...